Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816880 · ClinicalTrials.gov registry record
Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 15
- Enrollment target
NCT01816880 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 15 participants.
The verdict
NCT01816880 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The aim of this sub-study is to determine whether healthy individuals over 90 years of age possess immune cells that are involved in protection from chronic disease. The immune system is well known to produce anti-cancer and other immune cells, called antibodies that can be beneficial to our health. In this study the investigators will evaluate the immune status of the healthy individuals over 90 years of age. The investigators will be focused on studying molecules known to be involved in cholesterol, cancer like those for prostate cancer and breast cancer, inflammatory diseases, and infectious diseases like influenza.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01816880
The ClinicalTrials.gov registry entry for NCT01816880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01816880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01816880 about?
NCT01816880 is a clinical study titled "Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort". The aim of this sub-study is to determine whether healthy individuals over 90 years of age possess immune cells that are involved in protection from chronic disease. The immune system is well known to produce anti-cancer and other immune cells, called antibodies that can be beneficial to our health....
What is the current status of trial NCT01816880?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT01816880?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.